CIBC Has Lowered Expectations for Boralex (TSE:BLX) Stock Price

Boralex (TSE:BLXGet Free Report) had its price target cut by stock analysts at CIBC from C$42.00 to C$40.00 in a report released on Wednesday,BayStreet.CA reports. The brokerage currently has an “outperform” rating on the stock. CIBC’s price objective would indicate a potential upside of 46.52% from the stock’s previous close.

Separately, BMO Capital Markets lowered their target price on Boralex from C$46.00 to C$45.00 in a research note on Friday, November 15th. Five equities research analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus price target of C$43.13.

Check Out Our Latest Analysis on BLX

Boralex Price Performance

BLX stock traded down C$1.73 during midday trading on Wednesday, reaching C$27.30. 196,223 shares of the company’s stock traded hands, compared to its average volume of 187,028. The company has a 50-day simple moving average of C$30.44 and a two-hundred day simple moving average of C$32.82. The company has a quick ratio of 1.54, a current ratio of 0.95 and a debt-to-equity ratio of 175.24. Boralex has a 1-year low of C$26.25 and a 1-year high of C$36.68. The company has a market cap of C$2.81 billion, a price-to-earnings ratio of 29.35, a PEG ratio of 2.01 and a beta of 0.46.

Boralex Company Profile

(Get Free Report)

Boralex Inc is an electric utility company involved in the development, construction, and operation of renewable energy power facilities. The company controls a portfolio of electricity producing plants that utilize wind, hydroelectric, thermal, and solar fuel sources. Most of Boralex’s plants rely on wind power, while a significant number also employ hydroelectric power.

Further Reading

Analyst Recommendations for Boralex (TSE:BLX)

Receive News & Ratings for Boralex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Boralex and related companies with MarketBeat.com's FREE daily email newsletter.